(Q43130393)

14 November 2017

Linezolid penetration into cerebrospinal fluid and brain tissue (English)

1 reference

14 November 2017

0 references

1 reference

1 reference

Tsona A

1

1 reference

14 November 2017

Metallidis S

2

1 reference

14 November 2017

Foroglou N

3

1 reference

14 November 2017

Selviaridis P

4

1 reference

14 November 2017

Chrysanthidis T

5

1 reference

14 November 2017

Lazaraki G

6

1 reference

14 November 2017

Papaioannou M

7

1 reference

14 November 2017

Nikolaidis J

8

1 reference

14 November 2017

Nikolaidis P

9

1 reference

14 November 2017

1 February 2010

1 reference

14 November 2017

Journal of Chemotherapy

1 reference

14 November 2017

22

1 reference

14 November 2017

1

1 reference

14 November 2017

17-19

1 reference

Oxazolidinone antibiotics.

14 November 2017

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.1.17

In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.1.17

Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.1.17

Linezolid for the treatment of central nervous system infections in neurosurgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.1.17

Antibiotic pharmacodynamics in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.1.17

Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infection with linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.1.17

Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.1.17

Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.1.17

Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.1.17

Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.1.17

Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.1.17

Blood-brain barrier permeability in staphylococcal cerebritis and early brain abscess.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.1.17

Methods for Quantifying the transport of drugs across brain barrier systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.1.17

In vitro activity of linezolid against key gram-positive organisms isolated in the united states: results of the LEADER 2004 surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.1.17

21 January 2018

Identifiers

DOI

10.1179/JOC.2010.22.1.17

1 reference

14 November 2017

1 reference